kriss personal page - To The Moon

kriss

No personal profile

2Follow

0Followers

0Topic

0Badge

2023-07-05

Great ariticle, would you like to share it?

@港股窝轮Jenny:評估阿里巴巴(9988)窩輪市場的價值

2023-06-24

$Hang Seng Index - main 2306(HSImain)$

2023-06-22

$Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357)$

2023-06-22

$Metro One Telecommunications, Inc.(WOWI)$

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4150288344443602","uuid":"4150288344443602","gmtCreate":1687185232437,"gmtModify":1687185723208,"name":"kriss","pinyin":"kriss","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":2,"tweetSize":4,"questionSize":0,"limitLevel":999,"accountStatus":2,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":194770261131384,"gmtCreate":1688571257400,"gmtModify":1688573221950,"author":{"id":"4150288344443602","authorId":"4150288344443602","name":"kriss","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4150288344443602","authorIdStr":"4150288344443602"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/194770261131384","repostId":"194511123763240","repostType":1,"repost":{"id":194511123763240,"gmtCreate":1688526213404,"gmtModify":1688526213602,"author":{"id":"7437623982229841","authorId":"7437623982229841","name":"港股窝轮Jenny","avatar":"https://static.laohu8.com/0fad9f5f3130e11cc25ccdd193d54aa1","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"7437623982229841","authorIdStr":"7437623982229841"},"themes":[],"title":"評估阿里巴巴(9988)窩輪市場的價值","htmlText":"個股表現 <a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 現跌逾1%，低見82.85，失守多條平均線。最近10個交易日當中，阿里巴巴股價錄得7日下跌，在此期間下跌了5.94%。 衍生品表現 阿里巴巴認購證街貨減少3.%。2023年12月到期，價外20% 的認購證街貨增加最為明顯。其次為2023年10月到期，價外10% 的認購證為第二大街貨增加產品。阿里巴巴認購證整體成交額減少23.8%。 阿里巴巴認沽證街貨減少11.3%，；其次為2023年12月到期，價內20% 的認沽證為第二大街貨增加產品。阿里巴巴認沽證整體成交額減少54.8%。 阿里巴巴牛證街貨增加2.6%，2023年12月到期，收回價10% 的牛證街貨增加最為明顯；其次為2023年11月到期，收回價10% 的牛證為第二大街貨增加產品。阿里巴巴牛證整體成交額減少51.%。 阿里巴巴熊證街貨增加1.6%，2024年4月到期，收回價10% 的熊證街貨增加最為明顯；其次為2024年1月到期，收回價10% 的熊證為第二大街貨增加產品。阿里巴巴熊證整體成交額減少53.4%。 &nbsp; 技術信號與分析 根據技術系統分析阿里巴巴上升機會率47.1%，RSI數值49，指標信號有1個看好指標，6個看淡指標。即市阻力位86.4，若升穿阻力位上望90.4。即市支持位80.6，跌穿則有可能下試78.3。 衍生品展望 阿里巴巴即市阻力位86.4。考慮在阻力位附近看淡，行使價86，2023年12月到期的認沽證產品，可以考慮13884，引伸波幅最低，實際槓桿4.1倍。其次可以考慮14068，引伸波幅41.9%，實際槓桿3倍。進取投資者通常考慮價外認沽證產品，行使價可以參考即市支持位80.6。引伸波幅同樣較低的產品有17872及17835行使價分別為81.95與81.95元，實際","listText":"個股表現 <a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 現跌逾1%，低見82.85，失守多條平均線。最近10個交易日當中，阿里巴巴股價錄得7日下跌，在此期間下跌了5.94%。 衍生品表現 阿里巴巴認購證街貨減少3.%。2023年12月到期，價外20% 的認購證街貨增加最為明顯。其次為2023年10月到期，價外10% 的認購證為第二大街貨增加產品。阿里巴巴認購證整體成交額減少23.8%。 阿里巴巴認沽證街貨減少11.3%，；其次為2023年12月到期，價內20% 的認沽證為第二大街貨增加產品。阿里巴巴認沽證整體成交額減少54.8%。 阿里巴巴牛證街貨增加2.6%，2023年12月到期，收回價10% 的牛證街貨增加最為明顯；其次為2023年11月到期，收回價10% 的牛證為第二大街貨增加產品。阿里巴巴牛證整體成交額減少51.%。 阿里巴巴熊證街貨增加1.6%，2024年4月到期，收回價10% 的熊證街貨增加最為明顯；其次為2024年1月到期，收回價10% 的熊證為第二大街貨增加產品。阿里巴巴熊證整體成交額減少53.4%。 &nbsp; 技術信號與分析 根據技術系統分析阿里巴巴上升機會率47.1%，RSI數值49，指標信號有1個看好指標，6個看淡指標。即市阻力位86.4，若升穿阻力位上望90.4。即市支持位80.6，跌穿則有可能下試78.3。 衍生品展望 阿里巴巴即市阻力位86.4。考慮在阻力位附近看淡，行使價86，2023年12月到期的認沽證產品，可以考慮13884，引伸波幅最低，實際槓桿4.1倍。其次可以考慮14068，引伸波幅41.9%，實際槓桿3倍。進取投資者通常考慮價外認沽證產品，行使價可以參考即市支持位80.6。引伸波幅同樣較低的產品有17872及17835行使價分別為81.95與81.95元，實際","text":"個股表現 $阿里巴巴-SW(09988)$ 現跌逾1%，低見82.85，失守多條平均線。最近10個交易日當中，阿里巴巴股價錄得7日下跌，在此期間下跌了5.94%。 衍生品表現 阿里巴巴認購證街貨減少3.%。2023年12月到期，價外20% 的認購證街貨增加最為明顯。其次為2023年10月到期，價外10% 的認購證為第二大街貨增加產品。阿里巴巴認購證整體成交額減少23.8%。 阿里巴巴認沽證街貨減少11.3%，；其次為2023年12月到期，價內20% 的認沽證為第二大街貨增加產品。阿里巴巴認沽證整體成交額減少54.8%。 阿里巴巴牛證街貨增加2.6%，2023年12月到期，收回價10% 的牛證街貨增加最為明顯；其次為2023年11月到期，收回價10% 的牛證為第二大街貨增加產品。阿里巴巴牛證整體成交額減少51.%。 阿里巴巴熊證街貨增加1.6%，2024年4月到期，收回價10% 的熊證街貨增加最為明顯；其次為2024年1月到期，收回價10% 的熊證為第二大街貨增加產品。阿里巴巴熊證整體成交額減少53.4%。 技術信號與分析 根據技術系統分析阿里巴巴上升機會率47.1%，RSI數值49，指標信號有1個看好指標，6個看淡指標。即市阻力位86.4，若升穿阻力位上望90.4。即市支持位80.6，跌穿則有可能下試78.3。 衍生品展望 阿里巴巴即市阻力位86.4。考慮在阻力位附近看淡，行使價86，2023年12月到期的認沽證產品，可以考慮13884，引伸波幅最低，實際槓桿4.1倍。其次可以考慮14068，引伸波幅41.9%，實際槓桿3倍。進取投資者通常考慮價外認沽證產品，行使價可以參考即市支持位80.6。引伸波幅同樣較低的產品有17872及17835行使價分別為81.95與81.95元，實際","images":[{"img":"https://static.tigerbbs.com/8cb1e7640af5fed1997afa366f12a3c6","width":"931","height":"532"},{"img":"https://static.tigerbbs.com/1104bc3ff372d5610b37a9f4b1292746","width":"926","height":"472"},{"img":"https://static.tigerbbs.com/fb3bf60ac0c08db6364c0ba0b925165a","width":"934","height":"534"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/194511123763240","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190692216332416,"gmtCreate":1687581239650,"gmtModify":1687585747665,"author":{"id":"4150288344443602","authorId":"4150288344443602","name":"kriss","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4150288344443602","authorIdStr":"4150288344443602"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUT/HSImain\">$Hang Seng Index - main 2306(HSImain)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/FUT/HSImain\">$Hang Seng Index - main 2306(HSImain)$ &nbsp;</a>","text":"$Hang Seng Index - main 2306(HSImain)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190692216332416","isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190114538066144,"gmtCreate":1687440353795,"gmtModify":1687440995846,"author":{"id":"4150288344443602","authorId":"4150288344443602","name":"kriss","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4150288344443602","authorIdStr":"4150288344443602"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/300357\">$Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/300357\">$Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357)$ &nbsp;</a>","text":"$Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190114538066144","isVote":1,"tweetType":1,"viewCount":35,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190114416292064,"gmtCreate":1687440324066,"gmtModify":1687440991883,"author":{"id":"4150288344443602","authorId":"4150288344443602","name":"kriss","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4150288344443602","authorIdStr":"4150288344443602"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/WOWI\">$Metro One Telecommunications, Inc.(WOWI)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/WOWI\">$Metro One Telecommunications, Inc.(WOWI)$ &nbsp;</a>","text":"$Metro One Telecommunications, Inc.(WOWI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190114416292064","isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":194770261131384,"gmtCreate":1688571257400,"gmtModify":1688573221950,"author":{"id":"4150288344443602","authorId":"4150288344443602","name":"kriss","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4150288344443602","authorIdStr":"4150288344443602"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/194770261131384","repostId":"194511123763240","repostType":1,"repost":{"id":194511123763240,"gmtCreate":1688526213404,"gmtModify":1688526213602,"author":{"id":"7437623982229841","authorId":"7437623982229841","name":"港股窝轮Jenny","avatar":"https://static.laohu8.com/0fad9f5f3130e11cc25ccdd193d54aa1","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"7437623982229841","authorIdStr":"7437623982229841"},"themes":[],"title":"評估阿里巴巴(9988)窩輪市場的價值","htmlText":"個股表現 <a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 現跌逾1%，低見82.85，失守多條平均線。最近10個交易日當中，阿里巴巴股價錄得7日下跌，在此期間下跌了5.94%。 衍生品表現 阿里巴巴認購證街貨減少3.%。2023年12月到期，價外20% 的認購證街貨增加最為明顯。其次為2023年10月到期，價外10% 的認購證為第二大街貨增加產品。阿里巴巴認購證整體成交額減少23.8%。 阿里巴巴認沽證街貨減少11.3%，；其次為2023年12月到期，價內20% 的認沽證為第二大街貨增加產品。阿里巴巴認沽證整體成交額減少54.8%。 阿里巴巴牛證街貨增加2.6%，2023年12月到期，收回價10% 的牛證街貨增加最為明顯；其次為2023年11月到期，收回價10% 的牛證為第二大街貨增加產品。阿里巴巴牛證整體成交額減少51.%。 阿里巴巴熊證街貨增加1.6%，2024年4月到期，收回價10% 的熊證街貨增加最為明顯；其次為2024年1月到期，收回價10% 的熊證為第二大街貨增加產品。阿里巴巴熊證整體成交額減少53.4%。 &nbsp; 技術信號與分析 根據技術系統分析阿里巴巴上升機會率47.1%，RSI數值49，指標信號有1個看好指標，6個看淡指標。即市阻力位86.4，若升穿阻力位上望90.4。即市支持位80.6，跌穿則有可能下試78.3。 衍生品展望 阿里巴巴即市阻力位86.4。考慮在阻力位附近看淡，行使價86，2023年12月到期的認沽證產品，可以考慮13884，引伸波幅最低，實際槓桿4.1倍。其次可以考慮14068，引伸波幅41.9%，實際槓桿3倍。進取投資者通常考慮價外認沽證產品，行使價可以參考即市支持位80.6。引伸波幅同樣較低的產品有17872及17835行使價分別為81.95與81.95元，實際","listText":"個股表現 <a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 現跌逾1%，低見82.85，失守多條平均線。最近10個交易日當中，阿里巴巴股價錄得7日下跌，在此期間下跌了5.94%。 衍生品表現 阿里巴巴認購證街貨減少3.%。2023年12月到期，價外20% 的認購證街貨增加最為明顯。其次為2023年10月到期，價外10% 的認購證為第二大街貨增加產品。阿里巴巴認購證整體成交額減少23.8%。 阿里巴巴認沽證街貨減少11.3%，；其次為2023年12月到期，價內20% 的認沽證為第二大街貨增加產品。阿里巴巴認沽證整體成交額減少54.8%。 阿里巴巴牛證街貨增加2.6%，2023年12月到期，收回價10% 的牛證街貨增加最為明顯；其次為2023年11月到期，收回價10% 的牛證為第二大街貨增加產品。阿里巴巴牛證整體成交額減少51.%。 阿里巴巴熊證街貨增加1.6%，2024年4月到期，收回價10% 的熊證街貨增加最為明顯；其次為2024年1月到期，收回價10% 的熊證為第二大街貨增加產品。阿里巴巴熊證整體成交額減少53.4%。 &nbsp; 技術信號與分析 根據技術系統分析阿里巴巴上升機會率47.1%，RSI數值49，指標信號有1個看好指標，6個看淡指標。即市阻力位86.4，若升穿阻力位上望90.4。即市支持位80.6，跌穿則有可能下試78.3。 衍生品展望 阿里巴巴即市阻力位86.4。考慮在阻力位附近看淡，行使價86，2023年12月到期的認沽證產品，可以考慮13884，引伸波幅最低，實際槓桿4.1倍。其次可以考慮14068，引伸波幅41.9%，實際槓桿3倍。進取投資者通常考慮價外認沽證產品，行使價可以參考即市支持位80.6。引伸波幅同樣較低的產品有17872及17835行使價分別為81.95與81.95元，實際","text":"個股表現 $阿里巴巴-SW(09988)$ 現跌逾1%，低見82.85，失守多條平均線。最近10個交易日當中，阿里巴巴股價錄得7日下跌，在此期間下跌了5.94%。 衍生品表現 阿里巴巴認購證街貨減少3.%。2023年12月到期，價外20% 的認購證街貨增加最為明顯。其次為2023年10月到期，價外10% 的認購證為第二大街貨增加產品。阿里巴巴認購證整體成交額減少23.8%。 阿里巴巴認沽證街貨減少11.3%，；其次為2023年12月到期，價內20% 的認沽證為第二大街貨增加產品。阿里巴巴認沽證整體成交額減少54.8%。 阿里巴巴牛證街貨增加2.6%，2023年12月到期，收回價10% 的牛證街貨增加最為明顯；其次為2023年11月到期，收回價10% 的牛證為第二大街貨增加產品。阿里巴巴牛證整體成交額減少51.%。 阿里巴巴熊證街貨增加1.6%，2024年4月到期，收回價10% 的熊證街貨增加最為明顯；其次為2024年1月到期，收回價10% 的熊證為第二大街貨增加產品。阿里巴巴熊證整體成交額減少53.4%。 技術信號與分析 根據技術系統分析阿里巴巴上升機會率47.1%，RSI數值49，指標信號有1個看好指標，6個看淡指標。即市阻力位86.4，若升穿阻力位上望90.4。即市支持位80.6，跌穿則有可能下試78.3。 衍生品展望 阿里巴巴即市阻力位86.4。考慮在阻力位附近看淡，行使價86，2023年12月到期的認沽證產品，可以考慮13884，引伸波幅最低，實際槓桿4.1倍。其次可以考慮14068，引伸波幅41.9%，實際槓桿3倍。進取投資者通常考慮價外認沽證產品，行使價可以參考即市支持位80.6。引伸波幅同樣較低的產品有17872及17835行使價分別為81.95與81.95元，實際","images":[{"img":"https://static.tigerbbs.com/8cb1e7640af5fed1997afa366f12a3c6","width":"931","height":"532"},{"img":"https://static.tigerbbs.com/1104bc3ff372d5610b37a9f4b1292746","width":"926","height":"472"},{"img":"https://static.tigerbbs.com/fb3bf60ac0c08db6364c0ba0b925165a","width":"934","height":"534"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/194511123763240","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190692216332416,"gmtCreate":1687581239650,"gmtModify":1687585747665,"author":{"id":"4150288344443602","authorId":"4150288344443602","name":"kriss","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4150288344443602","authorIdStr":"4150288344443602"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/FUT/HSImain\">$Hang Seng Index - main 2306(HSImain)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/FUT/HSImain\">$Hang Seng Index - main 2306(HSImain)$ &nbsp;</a>","text":"$Hang Seng Index - main 2306(HSImain)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190692216332416","isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190114538066144,"gmtCreate":1687440353795,"gmtModify":1687440995846,"author":{"id":"4150288344443602","authorId":"4150288344443602","name":"kriss","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4150288344443602","authorIdStr":"4150288344443602"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/300357\">$Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/300357\">$Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357)$ &nbsp;</a>","text":"$Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.(300357)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190114538066144","isVote":1,"tweetType":1,"viewCount":35,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190114416292064,"gmtCreate":1687440324066,"gmtModify":1687440991883,"author":{"id":"4150288344443602","authorId":"4150288344443602","name":"kriss","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4150288344443602","authorIdStr":"4150288344443602"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/WOWI\">$Metro One Telecommunications, Inc.(WOWI)$ &nbsp;</a>","listText":"<a href=\"https://ttm.financial/S/WOWI\">$Metro One Telecommunications, Inc.(WOWI)$ &nbsp;</a>","text":"$Metro One Telecommunications, Inc.(WOWI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/190114416292064","isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}